PGIM India Healthcare Fund Regular-Growth
Equity
Sectoral-Pharma
₹-0.33% 1D
NAV on
Overview
Chart
Returns
Asset Allocation
Fund Info
Risk & Return Ratio
Fund Overview
- Rating
Not Rated - Minimum Investment₹5000
- NAV (Net Asset Value)₹N/A
- AUM (Fund size)₹126 Cr
- Created on5 Dec 2024
Fund Ranking
#
/ 18 in Sectoral-Pharma
Risk Level
Very High
Very High
Loading...
Returns
Trailing Return
Rolling Return
- 6 Month20.4%
- 1 Year22.4%
- 3 Year (CAGR)-
- All Time (CAGR)11.5%
Category Return
- 6 Month16.2%
- 1 Year15.1%
- 3 Year (CAGR)20.7%
- All Time (CAGR)17.1%
Asset Allocation
- Equity94.6%
- Debt5.8%
- Other-0.3%
Top 5 Holdings
Top 5 Sectors
- Cipla2.23%
- Dr Agarwals Eye Hospital1.20%
- Ipca Laboratories0.51%
- Abbott India2.83%
- Lupin1.42%
Fund Information
- Expense Ratio2.61%
- Exit LoadExit load of 0.50%, if redeemed within 90 days.
- Lock-In PeriodNo Lock-In
Managed By
Puneet Pal
Nov 2024 - Present
Anandha Padmanabhan Anjeneyan
Nov 2024 - Present
Vivek Sharma
Nov 2024 - Present
Utsav Mehta
Nov 2024 - Present
Risk & Return Ratio
- Sharpe Ratio
Sharpe Ratio evaluates a fund's return relative to its risk. Higher values signify better risk-adjusted performance. 0.00 - Standard Deviation
Standard deviation measures the volatility of a fund's returns. The higher the value, the riskier the investment. 0.00 - Alpha
Alpha in mutual funds measures excess return relative to a benchmark, indicating a manager's skill at generating returns beyond market performance. 0.00 - Beta
Beta in mutual funds indicates a fund's sensitivity to market changes. A beta over 1 means it's more volatile than the market, while below 1 implies less volatility. 0.00